Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

ABBV-295

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

AbbVie · Phase 2 · Recruiting · Enrollment 360

NCT07752979

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
ABBV-295 Arm 1n/rn/rn/rn/r
ABBV-295 Arm 2n/rn/rn/rn/r
ABBV-295 Arm 3n/rn/rn/rn/r
ABBV-295 Arm 4n/rn/rn/rn/r
ABBV-295 Arm 5n/rn/rn/rn/r
ABBV-295 Arm 6n/rn/rn/rn/r
Placebon/rn/rn/rn/r

Not shown

  • ABBV-295 Arm 1: endpoint not reported
  • ABBV-295 Arm 2: endpoint not reported
  • ABBV-295 Arm 3: endpoint not reported
  • ABBV-295 Arm 4: endpoint not reported
  • ABBV-295 Arm 5: endpoint not reported
  • ABBV-295 Arm 6: endpoint not reported
  • Placebo: endpoint not reported